Balyasny Asset Management
WGS icon

Balyasny Asset Management’s GeneDx Holdings WGS Stock Holding History

Balyasny Asset Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,341
Closed -$140K – 3167
2024
Q1 		$140K Buy
+15,341
New +$92.1K ﹤0.01% 2468
2022
Q2 		– Sell
-1,837
Closed -$186K – 3231
2022
Q1 		$186K Buy
+1,837
New +$204K ﹤0.01% 2039

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Balyasny Asset Management's WGS Position: Q2 2024 in Review

Balyasny Asset Management sold out of GeneDx Holdings (WGS) in Q2 2024, closing a stake of 15,341 shares — an estimated $140K sold.

Balyasny Asset Management first reported a position in WGS in Q1 2022 and held it in 2 quarters. The position peaked at $186K in Q1 2022. 86 funds tracked by Wall St. Rank hold WGS as of Q2 2024.

  • Balyasny Asset Management reported no remaining GeneDx Holdings position as of Q2 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 15,341 GeneDx Holdings shares in Q2 2024, an estimated $140K.
  • Balyasny Asset Management first reported a position in GeneDx Holdings in Q1 2022 and held it in 2 quarters.
  • Balyasny Asset Management's GeneDx Holdings position peaked at $186K in Q1 2022.
  • 86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.